These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9303518)

  • 21. Liver cirrhosis developed after ketoconazole-induced acute hepatic injury.
    Kim TH; Kim BH; Kim YW; Yang DM; Han YS; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1426-9. PubMed ID: 14675275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status.
    Lo Re V; Carbonari DM; Lewis JD; Forde KA; Goldberg DS; Reddy KR; Haynes K; Roy JA; Sha D; Marks AR; Schneider JL; Strom BL; Corley DA
    Am J Med; 2016 Mar; 129(3):283-91.e5. PubMed ID: 26597673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxic hepatitis during the administration of ketoconazole (Nizoral)].
    Kramer NJ; Montnor LP; Berghuis PH
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):343-4. PubMed ID: 6300703
    [No Abstract]   [Full Text] [Related]  

  • 24. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs.
    García Rodríguez LA; Duque A; Castellsague J; Pérez-Gutthann S; Stricker BH
    Br J Clin Pharmacol; 1999 Dec; 48(6):847-52. PubMed ID: 10594489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketoconazole-induced hepatitis: a case with a definite cause-effect relationship.
    van Parys G; Evenepoel C; van Damme B; Desmet VJ
    Liver; 1987 Feb; 7(1):27-30. PubMed ID: 2952860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis and ketoconazole therapy.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1058-9. PubMed ID: 6271330
    [No Abstract]   [Full Text] [Related]  

  • 27. The Rise and Fall of Oral Ketoconazole.
    Gupta AK; Lyons DC
    J Cutan Med Surg; 2015; 19(4):352-7. PubMed ID: 25775613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxic hepatitis caused by ketoconazole].
    Ned Tijdschr Geneeskd; 1983 Jun; 127(25):1114-5. PubMed ID: 6308481
    [No Abstract]   [Full Text] [Related]  

  • 29. Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis.
    Wang Y; Geizhals S; Lipner SR
    J Am Acad Dermatol; 2021 Feb; 84(2):497-499. PubMed ID: 32387655
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug safety assessment of oral formulations of ketoconazole.
    Gupta AK; Daigle D; Foley KA
    Expert Opin Drug Saf; 2015 Feb; 14(2):325-34. PubMed ID: 25409549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe hepatitis during ketoconazole therapy.
    Okumura H; Aramaki T; Satomura K; Iizuka K; Ohta M; Katsuta Y; Akaike M; Terada H; Kusunoki T
    Gastroenterol Jpn; 1983 Apr; 18(2):142-7. PubMed ID: 6303886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatotoxicity caused by ketoconazole].
    Cabeza Lamban F; Simal Gil E; Mur Villacampa M; Guerrero Navarro L
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):92. PubMed ID: 2799042
    [No Abstract]   [Full Text] [Related]  

  • 33. Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
    Vong CH; Forest M; Nicolino M
    J Pediatr; 2009 Mar; 154(3):467-8; author reply 468-9. PubMed ID: 19874777
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic hepatitis following ketoconazole treatment.
    Svedhem A
    Scand J Infect Dis; 1984; 16(1):123-5. PubMed ID: 6320358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of benefit against risk of ketoconazole therapy.
    Seebacher C
    Ther Hung; 1986; 34(4):227-32. PubMed ID: 2966995
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
    Tkach JR; Rinaldi MG
    Cutis; 1982 May; 29(5):482-4. PubMed ID: 6284445
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic dysfunction and ketoconazole therapy.
    Svejgaard E; Ranek L
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):788-9. PubMed ID: 6283980
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxic hepatis during ketoconazole treatment.
    Heiberg JK; Svejgaard E
    Br Med J (Clin Res Ed); 1981 Sep; 283(6295):825-6. PubMed ID: 6271328
    [No Abstract]   [Full Text] [Related]  

  • 40. Ketoconazole: assessing its risks.
    Stern RS
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):544. PubMed ID: 6281317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.